Sarepta Therapeutics Set to Join S&P MidCap 400

PR Newswire
Wednesday, May 29, 2024 at 9:48pm UTC

Sarepta Therapeutics Set to Join S&P MidCap 400

PR Newswire

NEW YORK, May 29, 2024 /PRNewswire/ -- Sarepta Therapeutics Inc. (NASD: SRPT) will replace Shockwave Medical Inc. (NASD: SWAV) in the S&P MidCap 400 effective prior to the opening of trading on Monday, June 3. S&P 500 constituent Johnson & Johnson (NYSE: JNJ) is acquiring Shockwave Medical in a deal expected to be completed soon pending final closing conditions.

Following is a summary of the changes that will take place prior to the open of trading on the effective date:

Effective Date

Index Name      


Company Name


GICS Sector

June 3, 2024

S&P MidCap 400


Sarepta Therapeutics


Health Care

June 3, 2024

S&P MidCap 400


Shockwave Medical


Health Care

For more information about S&P Dow Jones Indices, please visit


S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit


S&P Dow Jones Indices

Media Inquiries

Cision View original content:

SOURCE S&P Dow Jones Indices